Posts Tagged EMA

Up in the air

PME Pharmaceutical Market Europe May 2017

Stranger things have been said by politicians, particularly recently, but I can’t have been the only person surprised by Greg Clark’s turn at this year’s ABPI annual conference.

Asked about the EMA Clark, the UK government’s spokesperson for business, energy and industrial strategy, told the UK pharma gathering he wanted “as many [European] institutions here as possible”, adding: “I would like the EMA to continue to be within the UK.”

Meanwhile, in the real world, the temperature is certainly rising on the issue of where Europe’s regulatory authority will be located, with ‘not in the UK’ seemingly the only certainty at the moment. A decision from the EU’s heads of government is expected in the Autumn, and Copenhagen, Barcelona, Dublin and Lisbon are among those stepping up their public campaigns to host the EMA. Read the rest of this entry »

Advertisements

, , , , , ,

Leave a comment

Ready to start?

PME Pharmaceutical Market Europe January 2017

As PME‘s first issue of the year comes out the European pharmaceutical industry goes into 2017 steeling itself for the start of Brexit, with plenty of words already devoted to what we don’t know about the implications of the UK’s vote to leave the European Union.

This year should see the phony war end and hostilities begin in earnest when the UK formally triggers Article 50 and commences the official process of withdrawing from the EU. Read the rest of this entry »

, , , ,

Leave a comment

2016? We’ve been set up

In screenwriting the three-act structure progresses from setup to confrontation to resolution, with the first act used for establishing the main characters.

It’s a device for fiction of course, but much of this year feels like just that. In fact, looking back on the last 12 months, 2016 also feels like a setup for events yet to come. Read the rest of this entry »

, , , ,

Leave a comment

%d bloggers like this: